Drug maker Aurobindo Pharma has said that it has received tentative
approval from the US drug regulator for manufacturing and marketing of
its anti HIV infection tablets. The company has received United States
Food and Drug Administration's (USFDA) tentative approval for Abacavir
Sulfate and Lamivudine tablets, which is used for the treatment of HIV
infections, Aurobindo Pharma said in a filing to BSE.
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More